Search - tctmd.com

Displaying 281 - 300 of 625

Sort: Relevancy | Date

News Daily News

Medtronic’s HeartWare HVAD Recalled for Pump Weld Defect

L.A. McKeown

April 29, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

News Daily News

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

Todd Neale

April 20, 2022

News Daily News

Infertility in Women Linked to Subsequent Risk of HFpEF

L.A. McKeown

April 19, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Daily News

Cardiac Complications Higher After COVID-19 Than Vaccination

Shelley Wood

April 14, 2022

News Daily News

Myopericarditis No More Common After COVID-19 Shots Than Other Vaccines

Caitlin E. Cox

April 12, 2022

News Daily News

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

Caitlin E. Cox

March 31, 2022

News Daily News

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Michael O'Riordan

March 28, 2022

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

Heart Transplant Recipients Fare Poorer When Stroke Is Cause of Death for Younger Donors

Yael L. Maxwell

March 17, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Skipping Second Dose of mRNA COVID-19 Vaccine May Limit Myocarditis in Adolescents

Todd Neale

February 25, 2022

News Daily News

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

Yael L. Maxwell

February 24, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Shelley Wood

February 22, 2022

News Daily News

Robert M. Califf Becomes 25th Commissioner of the US FDA

L.A. McKeown

February 15, 2022

News Daily News

Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults

L.A. McKeown

February 15, 2022

Advertisement

Medtronic’s HeartWare HVAD Recalled for Pump Weld Defect

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

Infertility in Women Linked to Subsequent Risk of HFpEF

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Cardiac Complications Higher After COVID-19 Than Vaccination

Myopericarditis No More Common After COVID-19 Shots Than Other Vaccines

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

Heart Transplant Recipients Fare Poorer When Stroke Is Cause of Death for Younger Donors

Guideline-Directed Therapies Underused in Frail HF Patients

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Skipping Second Dose of mRNA COVID-19 Vaccine May Limit Myocarditis in Adolescents

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

FDA Approves Empagliflozin for Treatment of HFpEF

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Robert M. Califf Becomes 25th Commissioner of the US FDA

Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content